ANNUAL REPORT 2008/09 - Sonova

Changes in outstanding
WARs/SARs 2008/09 2007/08
Number of
WARs
106 CONSOLIDATED FINANCIAL STATEMENTS
Weighted
average
exercise
price (CHF)
Number of
SARs
Weighted
average
exercise
price (CHF)
Number of
WARs
Weighted
average
exercise
price (CHF)
Number of
SARs
Weighted
average
exercise
price (CHF)
Outstanding WARs/SARs
at April 1 44,400 96.00 28,400 95.05 31,600 95.05
Granted
Exercised/sold
38,180 56.00 44,400 96.00
Forfeited
Outstanding WARs/SARs
(3,200) 95.05
at March 31 82,580 77.51 28,400 95.05 44,400 96.00 28,400 95.05
Exercisable at March 311)/2) 7,350 96.00 14,200 95.05 7,100 95.05
1) The intrinsic value of the SARs exercisable at March 31, 2009 amounts to CHF 0 (previous year CHF 0).
2) The intrinsic value of the WARs exercisable at March 31, 2009 amounts to CHF 0.
Shares – Executive Equity Award Plan
The value of an individual share granted is equal to the market price on the SIX Swiss Exchange on
the grant date. The shares are subject to a blocking period, which starts on the date the shares are granted.
The shares delivered under this plan are shares repurchased by the Group on the open stock market.
The cost of the shares granted as part of the EEAP program is expensed pro rata temporis over the expected
vesting period. Assumptions are made regarding the forfeiture rate which is adjusted during the vesting
period to ensure that in the end only a charge for vested amounts occurred.
Changes in outstanding shares 2008/09 2007/08
Number of
shares
Number of
shares
Restricted shares at April 1 160,710 156,377
Granted 104,979 63,999
Released (60,297) (55,035)
Forfeited (12,080) (4,631)
Restricted shares at March 31 193,312 160,710